Cord blood infusion aims to rescue cancer Patients' platelet counts
NCT ID NCT07441720
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single infusion of umbilical cord blood can safely raise platelet levels in cancer patients whose platelets have dropped due to chemotherapy or other cancer treatments. Researchers will enroll 25 people aged 12 to 65 and monitor their blood counts for 28 days after the infusion. The goal is to reduce the need for platelet transfusions and manage bleeding risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Hematology, Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a platelet-boosting drug shorten recovery after stem cell transplants?
- Cord blood cells aim to speed platelet recovery in transplant patients
- Platelet transfusions may influence blood vessel health in critically ill patients
- New drug strategy may reduce blood transfusions after organ transplants
- Blood test could predict bleeding risk in cancer patients
- New study tests rapid blood test to prevent bleeding emergencies in pregnancy